Anton Kiselev
Overview
Explore the profile of Anton Kiselev including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
179
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhuravlev M, Kiselev A, Orlova A, Egorov E, Drapkina O, Simonyan M, et al.
Clocks Sleep
. 2025 Jan;
7(1.
PMID: 39846529
This study involved 72 volunteers divided into two groups according to the apnea-hypopnea index (AHI): AHI>15 episodes per hour (ep/h) (main group, n=39, including 28 men, median AHI 44.15, median...
2.
Maretina M, Koroleva V, Shchugareva L, Glotov A, Kiselev A
Biomedicines
. 2024 Nov;
12(11).
PMID: 39595052
Spinal muscular atrophy (SMA) is a severe neuromuscular disorder that currently has an approved treatment for all forms of the disease. Previously, biomarkers were primarily used for diagnostic purposes, such...
3.
Khorev V, Kurkin S, Badarin A, Antipov V, Pitsik E, Andreev A, et al.
J Integr Neurosci
. 2024 Jul;
23(7):125.
PMID: 39082285
This review provides a comprehensive examination of recent developments in both neurofeedback and brain-computer interface (BCI) within the medical field and rehabilitation. By analyzing and comparing results obtained with various...
4.
Al-Hilal H, Maretina M, Egorova A, Glotov A, Kiselev A
Methods Protoc
. 2024 Feb;
7(1).
PMID: 38392683
Spinal muscular atrophy is a neuromuscular disorder caused by mutations in both copies of the survival motor neuron gene 1 (), which lead to reduction in the production of the...
5.
Kiselev A, Maretina M, Shtykalova S, Al-Hilal H, Maslyanyuk N, Plokhih M, et al.
Int J Neonatal Screen
. 2024 Feb;
10(1).
PMID: 38390973
Spinal muscular atrophy 5q (SMA) is one of the most common neuromuscular inherited diseases and is the most common genetic cause of infant mortality. SMA is associated with homozygous deletion...
6.
Egorova A, Shtykalova S, Maretina M, Freund S, Selutin A, Shved N, et al.
Int J Mol Sci
. 2024 Jan;
25(1).
PMID: 38203202
Uterine leiomyoma (UL) is a prevalent benign tumor in women that frequently gives rise to a multitude of reproductive complications. The use of suicide gene therapy has been proposed as...
7.
Egorova A, Maretina M, Krylova I, Kiselev A
Int J Mol Sci
. 2024 Jan;
25(1).
PMID: 38203184
Endometriosis (EM) is a prevalent gynecological disease characterized by the abnormal growth of tissue similar to the endometrium outside of the uterus. This condition is accompanied by the development of...
8.
Maretina M, Ilina A, Egorova A, Glotov A, Kiselev A
Biomedicines
. 2023 Nov;
11(11).
PMID: 38002071
Spinal muscular atrophy (SMA) is a devastating neurodegenerative disease caused by mutations in the gene. Existing therapies demonstrate positive results on SMA patients but still might be ameliorated in efficacy...
9.
Egorova A, Petrosyan M, Maretina M, Bazian E, Krylova I, Baranov V, et al.
Pharmaceutics
. 2023 Aug;
15(8).
PMID: 37631322
Anti-angiogenic RNAi-based therapy can be considered as a possible strategy for the treatment of endometriosis (EM), which is the most common gynecological disease. Targeted delivery of siRNA therapeutics is a...
10.
Zhuravlev M, Agaltsov M, Kiselev A, Simonyan M, Novikov M, Selskii A, et al.
Sci Rep
. 2023 May;
13(1):8444.
PMID: 37231107
We performed a mathematical analysis of functional connectivity in electroencephalography (EEG) of patients with obstructive sleep apnea (OSA) (N = 10; age: 52.8 ± 13 years; median age: 49 years;...